ANTIHYPERTENSIVE DRUG WITHDRAWAL SYNDROMECUMMINGS DM; VLASSES PH.1982; DRUG INTELLIGENCE & CLINICAL PHARMACY; ISSN 0012-6578; USA; DA. 1982; VOL. 16; NO 11; PP. 817-822; BIBL. 66 REF.Article

CLINICAL PHARMACOLOGY AND THERAPEUTIC APPLICATIONS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CAPTOPRILFERGUSON RK; VLASSES PH.1981; AM. HEART. J.; ISSN 0002-8703; USA; DA. 1981; VOL. 101; NO 5; PP. 650-656; BIBL. 57 REF.Article

INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME: THERAPEUTIC IMPLICATIONSROTMENSCH HH; VLASSES PH; FERGUSON RK et al.1982; ISRAEL JOURNAL OF MEDICAL SCIENCES; ISSN 0021-2180; ISR; DA. 1982; VOL. 18; NO 10; PP. 981-985; BIBL. 39 REF.Article

CLINICAL USE OF CAPTOPRIL: ILLUSTRATIVE CASESFERGUSON RK; ROTMENSCH HH; VLASSES PH et al.1982; JAMA, J AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 247; NO 15; PP. 2117-2119; BIBL. 8 REF.Article

EFFECTS OF CAPTOPRIL, DIURETIC, AND THEIR COMBINATION IN LOW-RENIN ESSENTIAL HYPERTENSIONFERGUSON RK; VLASSES PH; SWANSON BN et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 25-26; PP. 2519-2522; BIBL. 17 REF.Article

"SCALDED MOUTH" CAUSED BY ANGIOTENSIN-CONVERTING-ENZYME INHIBITORSVLASSES PH; ROTMENSCH HH; FERGUSON RK et al.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 63300; PP. 1672-1673; BIBL. 5 REF.Article

NORFLOXACIN DISPOSITION AFTER SEQUENTIALLY INCREASING ORAL DOSESSWANSON BN; BOPPANA VK; VLASSES PH et al.1983; ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; ISSN 0066-4804; USA; DA. 1983; VOL. 23; NO 2; PP. 284-288; BIBL. 7 REF.Article

INFLUENCE OF CIMETIDINE ON THE PHARMACOKINETICS OF MORPHINE IN RATSMOJAVERIAN P; SWANSON BN; DUDASH ML et al.1982; RES. COMMUN. SUBST. ABUSE; ISSN 504122; USA; DA. 1982; VOL. 3; NO 1; PP. 1-10; BIBL. 2 P.Article

LOW-DOSE CAPTOPRILVLASSES PH; ROTMENSCH HH; SWANSON BN et al.1982; ARCH. INTERN. MED. (1960); ISSN 0003-9926; USA; DA. 1982; VOL. 142; NO 6; PP. 1098-1101; BIBL. 28 REF.Article

CAPTOPRIL WITHDRAWAL AFTER CHRONIC THERAPYVLASSES PH; KOFFER H; FERGUSON RK et al.1981; CLIN. EXP. HYPERTENS.; ISSN 0148-3927; USA; DA. 1981; VOL. 3; NO 5; PP. 929-937; BIBL. 14 REF.Article

SULINDAC DISPOSITION WHEN GIVEN ONCE AND TWICE DAILYSWANSON BN; BOPPANA VK; VLASSES PH et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 3; PP. 397-403; BIBL. 19 REF.Article

IMMEDIATE-RELEASE AND SUSTAINED-RELEASE PROCAINAMIDE: BIOAVAILABILITY AT STEADY STATE IN CARDIAC PATIENTSVLASSES PH; ROCCI ML JR; PORRINI KA et al.1983; ANNALS OF INTERNAL MEDICINE; ISSN 0003-4819; USA; DA. 1983; VOL. 98; NO 5; PP. 613-614; BIBL. 6 REF.Article

RELATIONSHIPS AMONG TIMOLOL DOSES, PLASMA CONCENTRATIONS AND BETA -ADRENOCEPTOR BLOCKING ACTIVITYFERGUSON RK; VLASSES PH; KOPLIN JR et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 5; PP. 719-725; BIBL. 16 REF.Article

CAPTOPRIL IN SEVERE TREATMENT-RESISTANT HYPERTENSIONFERGUSON RK; VLASSES PH; KOPLIN SR et al.1980; AMER. HEART J.; USA; DA. 1980; VOL. 99; NO 5; PP. 579-585; BIBL. 15 REF.Article

ANGIOTENSIN CONVERTING ENZYME ACTIVITY IN HUMAN SERUM RELATIONSHIP TO ENZYME INHIBITOR IN VIVO AND IN VITROSWANSON BN; HICHENS M; PARVIZ MOJAVERIAN et al.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 33; NO 3; PP. 525-536; BIBL. 3 P.Article

COMPARISON OF ORAL INDACRINONE WITH FUROSEMIDEIRVIN JD; VLASSES PH; HUBER PB et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 3; PP. 376-383; BIBL. 14 REF.Article